Ítem
Solo Metadatos
5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction
Título de la revista
Autores
García?Perdomo, Herney A
Lopez, Hugo E
Tacklind, James
Fecha
2015
Directores
ISSN de la revista
Título del volumen
Editor
John Wiley and Sons Ltd
Buscar en:
Métricas alternativas
Resumen
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). © 2015 The Cochrane Collaboration.
Palabras clave
Keywords
Dutasteride , Finasteride , Steroid 5alpha reductase inhibitor , Article , Benign prostatic obstruction , Clinical protocol , Disease association , Disease severity , Drug effect , Human , International prostate symptom score , Lower urinary tract symptom , Outcome assessment , Priority journal , Prostate disease , Quality of life , Systematic review , Urine retention , Urogenital tract disease assessment
